Predictmedix is an Artificial Intelligence company that has developed fast, non-invasive, contactless screening devices that detect infectious diseases, impairment and even mental illness at any location where mass amounts of people gather, such as:
- Hospitals
- Stadiums
- Airports
- Malls
- Government Buildings
- Office Complexes
These screeners are fully automated and intelligent, so they don’t need personnel to operate them. They determine the probability of a person being infected with illnesses such as COVID-19, so safety protocols can be initiated.
Earlier this month, the AI firm penned a major strategic partnership with Juiceworks and Connectus Global to deploy its Safe Entry Stations nationwide.
That news came during an increasingly busy time for $PMED, which has included:
- An LOI to acquire AI-powered tech firm Symp2Pass
- The engagement of investment banking firm Kingswood Capital Markets in preparation for NASDAQ listing
- Major partnerships
- Strategic financing developments
You’re going to want to get comfy for this chat with Predictmedix COO & Director Rahul Kushwah:
Tags: AI, artificial intelligence, covid, covid screening, covid-19 screening, CSE, stocks, tsx